5F-NNE1

File:5F-NNE1 structure.png

5F-NNE1_structure.png

5F-NNE1 is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the cannabinoid receptors and has been associated with various adverse effects.

Chemical Structure and Properties

5F-NNE1, also known as 5F-NNEI, is chemically classified as an indazole-based synthetic cannabinoid. Its full chemical name is 1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-indazole-3-carboxamide. The compound features a fluorinated pentyl chain, which is a common modification in synthetic cannabinoids to enhance their potency.

Pharmacology

5F-NNE1 acts as a potent agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including pain sensation, mood, and appetite.

Legal Status

The legal status of 5F-NNE1 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and adverse health effects. For example, in the United States, it is listed as a Schedule I controlled substance under the Controlled Substances Act.

Health Effects and Risks

The use of 5F-NNE1 has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, and psychosis. Due to its high potency, there is a significant risk of overdose, which can lead to severe health complications or death.

Detection in Biological Samples

5F-NNE1 can be detected in biological samples using various analytical techniques such as gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). These methods are commonly used in forensic and clinical toxicology to identify the presence of synthetic cannabinoids.

Regulation and Control

Due to the health risks associated with synthetic cannabinoids like 5F-NNE1, many countries have implemented strict regulations to control their distribution and use. These regulations aim to reduce the prevalence of these substances and mitigate their impact on public health.

See Also

• Synthetic cannabinoid
• Cannabinoid receptor
• Endocannabinoid system
• Designer drug